COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down

COO dropped 15.9% after-hours following its Q3 report that mixed an earnings beat with a revenue miss and cautious Q4 guidance. The company posted adjusted EPS of $1.15, topping estimates by 3.6%, but revenue of $1.066 billion fell short by 3.0%.

CooperVision drove the revenue shortfall as U.S. channel inventory reductions pressured sales. CooperSurgical delivered a 2% revenue gain, offsetting some of the weakness. Management warned that destocking headwinds will persist into Q4, though the company noted underlying U.S. consumption trends remain healthy.

The double-digit after-hours decline reflects trader concern over near-term top-line visibility despite the bottom-line beat. The inventory correction at CooperVision, the larger of the two segments, appears to be the primary driver of the selloff as the market weighs temporary destocking against management's assertion of solid end-market demand.